Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell Lines
Sarah Straud, Iryna Zubovych, Jef K. De Brabander et al. · 2010
Read Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell Lines by Sarah Straud, Iryna Zubovych, Jef K. De Brabander et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011629.txt.
Description
Sarah Straud and co-authors asked why some cancer cells die easily under a certain drug class, in PLOS ONE in 2010. The drugs block V-ATPases, pumps that keep the inside of cells at the right acidity. Many tumour cell lines are far more sensitive to these blockers than normal cells, for reasons that were unknown.
Using gene activity data across cell lines, the team traced the difference to iron. Blocking iron uptake proved responsible for the uneven sensitivity. The link turns a drug puzzle into a question of cell metabolism, and it hints that iron handling could predict which tumours these drugs might help.
Catalog record
| CREATOR | Sarah Straud, Iryna Zubovych, Jef K. De Brabander et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011629